Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.65 HKD | -0.38% | +1.92% | -28.95% |
Business Summary
Number of employees: 5,005
Sales per Business
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Oncology Drugs
38.5
%
| 1,704 | 27.2 % | 2,681 | 38.5 % | +57.33% |
Cardiovascular System Drugs
25.7
%
| 1,720 | 27.4 % | 1,786 | 25.7 % | +3.82% |
Central Nervous System Drugs
22.1
%
| 1,595 | 25.5 % | 1,538 | 22.1 % | -3.59% |
Alimentary Tract and Metabolism Drugs
10.6
%
| 1,083 | 17.3 % | 735 | 10.6 % | -32.09% |
Others
3.1
%
| 165 | 2.6 % | 215 | 3.1 % | +30.68% |
Sales per region
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
84.1
%
| 5,107 | 81.5 % | 5,851 | 84.1 % | +14.56% |
Asia (other than China)
5.7
%
| 535 | 8.5 % | 398 | 5.7 % | -25.55% |
European Union
5.2
%
| 294 | 4.7 % | 360 | 5.2 % | +22.22% |
Other Countries
5.0
%
| 331 | 5.3 % | 348 | 5.0 % | +4.94% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dian Bo Liu
CEO | Chief Executive Officer | 59 | 03-07-01 |
Rong Bing Yang
PSD | President | 58 | 94-06-07 |
Yun Li Xue
PRN | Corporate Officer/Principal | 60 | 94-06-07 |
Mei Yi Lee
SEC | Corporate Secretary | 56 | 20-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hui Xian Yuan
BRD | Director/Board Member | 65 | 94-06-07 |
Rong Bing Yang
PSD | President | 58 | 94-06-07 |
Dian Bo Liu
CEO | Chief Executive Officer | 59 | 03-07-01 |
Hua Qiao Zhang
BRD | Director/Board Member | 61 | 14-05-31 |
Yuk Lam Lo
BRD | Director/Board Member | 76 | 14-05-31 |
Sze Chung Choy
BRD | Director/Board Member | 65 | 14-05-31 |
Rui Lin Song
BRD | Director/Board Member | 61 | 17-03-28 |
Yuan Yuan Zhu
BRD | Director/Board Member | 43 | 09-07-31 |
Lin Xia
BRD | Director/Board Member | 67 | 23-05-24 |
Dong Lyu
BRD | Director/Board Member | 49 | Dec. 05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,549,670,643 | 1,950,149,832 ( 54.94 %) | 0 | 54.94 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
360,596,456 | 70.81% | 465,349,726 $ |
Company contact information
Luye Pharma Group Ltd.
No. 15 Chuang Ye Road High-Tech Industrial Development Zon
264003, Yantai
+
http://www.luye.cnSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.95% | 1.28B | |
+25.46% | 659B | |
+26.53% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.26% | 215B | |
+7.22% | 210B | |
-5.93% | 200B | |
-8.79% | 149B |
- Stock Market
- Equities
- 2186 Stock
- Company Luye Pharma Group Ltd.